These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9971914)

  • 1. Bioequivalence evaluation of two omeprazole enteric-coated formulations in humans.
    Farinha A; Bica A; Pais JP; Toscano MC; Tavares P
    Eur J Pharm Sci; 1999 Mar; 7(4):311-5. PubMed ID: 9971914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioequivalence and pharmacokinetic study of two different omeprazole capsule formulations in healthy Bangladeshi volunteers.
    Joti JJ; Nahar K; Hasan A; Azad MA; Ullah MA; Islam SM; Hasnat A
    Arzneimittelforschung; 2009; 59(4):171-5. PubMed ID: 19517893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relative bioavailability and pharmacokinetic study of omeprazole 20 mg enteric-coated tablet in healthy Bangladeshi volunteers.
    Hasan A; Abul Kalam Azad M; Ullah MA; Mahbub Latif AH; Hasnat A
    Int J Clin Pharmacol Ther; 2009 Mar; 47(3):215-21. PubMed ID: 19281731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bioavailability of omeprazole 20 mg capsules containing omeprazole 22.5% enteric coated pellets versus a reference product in healthy Bangladeshi male subjects: an open-label, single-dose, randomized-sequence, two-way crossover study.
    Islam MS; Trini AB; Shohag H; Ahmed MU; Maruf AA; Hasnat A
    Int J Clin Pharmacol Ther; 2011 Dec; 49(12):778-86. PubMed ID: 22122821
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and bioequivalence testing of five commercial formulations of omeprazole in the horse.
    Sykes BW; Underwood C; Greer R; McGowan CM; Mills PC
    J Vet Pharmacol Ther; 2016 Feb; 39(1):78-83. PubMed ID: 25989292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioequivalence between omeprazole MUPS 20 mg as tablet and omeprazole MUPS 20 mg as tablet encapsulated in a hard gelatine capsule.
    Schaltenbrand R; Huber R; Cotoraci CA; Mascher H; Potthast H; Hole U
    Int J Clin Pharmacol Ther; 2001 Oct; 39(10):453-9. PubMed ID: 11680670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioequivalence assessment of two capsule formulations of omeprazole in healthy volunteers.
    Hussein RF; Lockyer M; Hammami MM
    Arzneimittelforschung; 2007; 57(2):101-5. PubMed ID: 17396620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics during treatment with the omeprazole 20 mg enteric-coated tablet and 20 mg capsule in asymptomatic duodenal ulcer patients.
    Thomson AB; Kirdeikis P; Lastiwka R; Röhss K; Sinclair P; Olofsson B
    Can J Gastroenterol; 1997; 11(8):657-60. PubMed ID: 9459044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Omeprazole--a new formulation.
    Armstrong D
    Can J Gastroenterol; 1997; 11(8):655-6. PubMed ID: 9459043
    [No Abstract]   [Full Text] [Related]  

  • 10. Influence of food on the bioavailability of an enteric-coated tablet formulation of omeprazole 20 mg under repeated dose conditions.
    Thomson AB; Sinclair P; Matisko A; Rosen E; Andersson T; Olofsson B
    Can J Gastroenterol; 1997; 11(8):663-7. PubMed ID: 9459045
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Establishing Virtual Bioequivalence and Clinically Relevant Specifications for Omeprazole Enteric-Coated Capsules by Incorporating Dissolution Data in PBPK Modeling.
    Yang R; Lin Y; Chen K; Huang J; Yang S; Yao A; Yang X; Lei D; Xiao J; Yang G; Pei Q
    AAPS J; 2024 Jul; 26(4):82. PubMed ID: 38997548
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of intravenous, plain oral and enteric-coated oral omeprazole in the horse.
    Sykes BW; Underwood C; McGowan CM; Mills PC
    J Vet Pharmacol Ther; 2015 Apr; 38(2):130-6. PubMed ID: 25271390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of omeprazole with enteric-coated salicylate tablets.
    Nefesoglu FZ; Ayanoglu-Dülger G; Ulusoy NB; Imeryüz N
    Int J Clin Pharmacol Ther; 1998 Oct; 36(10):549-53. PubMed ID: 9799060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the proton pump inhibitor omeprazole on the pharmacokinetics of extended-release formulations of oxybutynin and tolterodine.
    Dmochowski R; Chen A; Sathyan G; MacDiarmid S; Gidwani S; Gupta S
    J Clin Pharmacol; 2005 Aug; 45(8):961-8. PubMed ID: 16027408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is it possible to achieve bio-equivalence between an oral solid immediate-release and an analogue enteric-coated formulation?
    Licht D; Cohen R; Spiegelstein O; Rabinovich-Guilatt L; Zholkovsky M; Gilbert A; Dressman JB; Safadi M
    J Pharm Pharmacol; 2016 Oct; 68(10):1278-89. PubMed ID: 27465906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the effect of orally administered acid suppressants on intragastric pH in cats.
    Parkinson S; Tolbert K; Messenger K; Odunayo A; Brand M; Davidson G; Peters E; Reed A; Papich MG
    J Vet Intern Med; 2015 Jan; 29(1):104-12. PubMed ID: 25537303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dissolution of omeprazole from delayed-release solid oral dosage forms.
    Farinha A; Bica A; Martins JM; Pais JP
    Drug Dev Ind Pharm; 2000 Jul; 26(7):785-90. PubMed ID: 10872100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability and efficacy of omeprazole given orally and by nasogastric tube.
    Larson C; Cavuto NJ; Flockhart DA; Weinberg RB
    Dig Dis Sci; 1996 Mar; 41(3):475-9. PubMed ID: 8617118
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bioequivalence evaluation of two rabeprazole enteric coated formulations in healthy Chinese volunteers.
    Chen J; Jiang WM; Gao XL; Jiang X; Zhang QZ; Zheng ZH
    Eur J Drug Metab Pharmacokinet; 2004; 29(2):103-6. PubMed ID: 15230337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Has the Time Come to Employ Population and Individual Bioequivalence for the Evaluation of Generics?
    Micheal F; Sayana M; Prasad R; Motilal BM
    Curr Drug Metab; 2020; 21(2):112-125. PubMed ID: 32234000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.